These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2699998)

  • 41. Prostanoids in paediatric kidney diseases.
    Seyberth HW; Leonhardt A; Tönshoff B; Gordjani N
    Pediatr Nephrol; 1991 Sep; 5(5):639-49. PubMed ID: 1911154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipid metabolism.
    Davidson J
    Curr Opin Lipidol; 1995 Jun; 6(3):U65-9. PubMed ID: 7647994
    [No Abstract]   [Full Text] [Related]  

  • 43. Eicosanoids and platelet activating factor as possible mediators of injury in experimental nephropathies.
    Remuzzi G
    Adv Exp Med Biol; 1989; 259():221-47. PubMed ID: 2696353
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of lipoproteins in progressive renal disease.
    Walli AK; Gröne E; Miller B; Gröne HJ; Thiery J; Seidel D
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):358S-366S. PubMed ID: 8297544
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal eicosanoids.
    Norris SH
    Semin Nephrol; 1990 Jan; 10(1):64-88. PubMed ID: 2104991
    [No Abstract]   [Full Text] [Related]  

  • 46. Renal eicosanoids. Based on a symposium. June 9-11, 1987, Capri, Italy. Proceedings.
    Adv Exp Med Biol; 1989; 259():1-421. PubMed ID: 2624238
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of protein intake on the progression of renal disease.
    Klahr S
    Annu Rev Nutr; 1989; 9():87-108. PubMed ID: 2669884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of renal eicosanoids in the control of intraglomerular and systemic blood pressure during development of hypertension.
    Arima S; Ito S
    Contrib Nephrol; 2004; 143():65-76. PubMed ID: 15248356
    [No Abstract]   [Full Text] [Related]  

  • 49. Eicosanoids in immune-mediated renal injury.
    Lianos EA
    Semin Nephrol; 1992 Sep; 12(5):441-53. PubMed ID: 1410868
    [No Abstract]   [Full Text] [Related]  

  • 50. Eicosanoids: potential regulators of extracellular matrix formation in the kidney.
    Kohan DE
    J Lab Clin Med; 1992 Jul; 120(1):4-6. PubMed ID: 1613326
    [No Abstract]   [Full Text] [Related]  

  • 51. The Dysregulation of Eicosanoids and Bile Acids Correlates with Impaired Kidney Function and Renal Fibrosis in Chronic Renal Failure.
    Wang YN; Hu HH; Zhang DD; Wu XQ; Liu JL; Guo Y; Miao H; Zhao YY
    Metabolites; 2021 Feb; 11(2):. PubMed ID: 33672315
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eicosanoids in corals and crustaceans: primary metabolites that function as allelochemicals and pheromones.
    Gerhart DJ; Clare AS; Eisenman K; Rittschof D; Forward RB
    Prog Clin Biol Res; 1990; 342():598-602. PubMed ID: 1974359
    [No Abstract]   [Full Text] [Related]  

  • 53. Lipid Metabolism Disorder and Renal Fibrosis.
    Du XG; Ruan XZ
    Adv Exp Med Biol; 2019; 1165():525-541. PubMed ID: 31399983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eicosanoids and the large intestine.
    Krause W; DuBois RN
    Prostaglandins Other Lipid Mediat; 2000 May; 61(3-4):145-61. PubMed ID: 10867126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eicosanoids and disease. Introduction.
    Spector AA; Campbell WB; Zeldin DC
    Prostaglandins Other Lipid Mediat; 2011 Nov; 96(1-4):1-2. PubMed ID: 22004919
    [No Abstract]   [Full Text] [Related]  

  • 56. Dietary restriction of phosphate in renal disease.
    Binswanger U
    N Engl J Med; 1978 Apr; 298(17):974-5. PubMed ID: 642983
    [No Abstract]   [Full Text] [Related]  

  • 57. Relevance of fatty acids and eicosanoids to clinical and preventive medicine.
    Schettler G
    Prog Lipid Res; 1986; 25(1-4):1-4. PubMed ID: 3423086
    [No Abstract]   [Full Text] [Related]  

  • 58. Eicosanoids and the small intestine.
    Mohajer B; Ma TY
    Prostaglandins Other Lipid Mediat; 2000 May; 61(3-4):125-43. PubMed ID: 10867125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipiduria in renal disease.
    Streather CP; Varghese Z; Moorhead JF; Scoble JE
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):353S-357S. PubMed ID: 8297543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of eicosanoids in the acute phase response.
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    J Hepatol; 1991 Mar; 12(2):268. PubMed ID: 1904896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.